Skip to main content
search
Menu
Home
About
News
Resources
Events
FAQ & Support
Programs
Laws and Regulations Governing Buprenorphine for OUD
Managing the Legal Risks of Prescribing Controlled Medications
Preparing for and Responding to DEA Visits
Prescribing Buprenorphine for OUD During a Public Health Emergency
search
Search
Close Search
Category
News
ED Visits for Opioid Poisonings Up 29%
February 10, 2021
Biden To Reverse Trump X Waiver Policy
January 25, 2021
Federal Gov’t Expands Access to Buprenorphine for OUD
January 14, 2021
DEA Expanding Surveillance of Prescription Drug Data
November 11, 2020
DEA Supercharges Patient, Prescriber, Pharmacist Surveillance
November 9, 2020
Stigma Against OUD Medications Persists
October 20, 2020
Prepare to E-Prescribe Controlled Drugs for Medicare Participants
July 28, 2020
FDA Recommends Discussing Naloxone When Prescribing Opioids
July 23, 2020
Drug Overdose Deaths Up 4.6% in 2019
July 16, 2020
DOJ Targets Pain Management Specialists
July 4, 2020
More
Close Menu
Home
About
News
Resources
Events
FAQ & Support
Programs
Laws and Regulations Governing Buprenorphine for OUD
Managing the Legal Risks of Prescribing Controlled Medications
Preparing for and Responding to DEA Visits
Prescribing Buprenorphine for OUD During a Public Health Emergency
